482 related articles for article (PubMed ID: 18524938)
1. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
2. Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response.
Webster JI; Carlstedt-Duke J
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):277-88. PubMed ID: 12589934
[TBL] [Abstract][Full Text] [Related]
3. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier.
Bauer B; Hartz AM; Lucking JR; Yang X; Pollack GM; Miller DS
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1222-34. PubMed ID: 18349876
[TBL] [Abstract][Full Text] [Related]
4. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
6. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
7. An electrically tight in vitro blood-brain barrier model displays net brain-to-blood efflux of substrates for the ABC transporters, P-gp, Bcrp and Mrp-1.
Helms HC; Hersom M; Kuhlmann LB; Badolo L; Nielsen CU; Brodin B
AAPS J; 2014 Sep; 16(5):1046-55. PubMed ID: 24934296
[TBL] [Abstract][Full Text] [Related]
8. Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice.
Gahir SS; Piquette-Miller M
Drug Metab Dispos; 2011 Mar; 39(3):465-71. PubMed ID: 21127142
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
[TBL] [Abstract][Full Text] [Related]
11. Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation.
Petropoulos S; Gibb W; Matthews SG
Brain Res; 2010 Oct; 1357():9-18. PubMed ID: 20709040
[TBL] [Abstract][Full Text] [Related]
12. Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane X receptor.
Zhang Y; Lu M; Sun X; Li C; Kuang X; Ruan X
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3508-15. PubMed ID: 22570346
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.
Vadlapatla RK; Vadlapudi AD; Kwatra D; Pal D; Mitra AK
Int J Pharm; 2011 Nov; 420(1):26-33. PubMed ID: 21864659
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
Campa D; Butterbach K; Slager SL; Skibola CF; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Kaaks R; Boffetta P; Brennan P; Conde L; Bracci PM; Caporaso NE; Strom SS; Camp NJ; Cerhan JR; ; Canzian F; Nieters A
Int J Cancer; 2012 Aug; 131(4):803-12. PubMed ID: 21918980
[TBL] [Abstract][Full Text] [Related]
15. Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats.
Gavins FKH; Dou L; Qin Y; Madla CM; Murdan S; Basit AW; Mai Y; Orlu M
Biomed Pharmacother; 2023 Apr; 160():114329. PubMed ID: 36731343
[TBL] [Abstract][Full Text] [Related]
16. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
[TBL] [Abstract][Full Text] [Related]
17. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
18. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
Wang X; Sykes DB; Miller DS
Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.
Martin P; Riley R; Back DJ; Owen A
Br J Pharmacol; 2008 Feb; 153(4):805-19. PubMed ID: 18037906
[TBL] [Abstract][Full Text] [Related]
20. Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats.
Mairinger S; Hernández-Lozano I; Filip T; Sauberer M; Löbsch M; Stanek J; Wanek T; Sake JA; Pekar T; Ehrhardt C; Langer O
J Control Release; 2022 Sep; 349():109-117. PubMed ID: 35798092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]